BTIG analyst Marie Thibault Quoted by Investor’s Business Daily – “IBD Stock Of The Day Dexcom Bounds Off A New Entry After Topping Bullish Calls”

BTIG analyst Marie Thibault said in a recent report:  “Commercial insurance companies are signing off on G7 coverage quicker than Dexcom anticipated.  Commentary sounded upbeat on G7 adoption.  Management confirmed their expectation that these new patients would contribute 1% of total revenue this year.  We think this remains a relatively conservative target given 75% of Dexcom reps are targeting (primary care physicians) and we think physician/patient awareness will increase into the catalyst.”  She kept her buy rating and 126 price target on Dexcom stock.